A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)
Public ClinicalTrials.gov record NCT03551522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Followed by an Open-Label Extension Period to Evaluate the Activity of Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 2, Double-Blind (DB), Randomized, Placebo-Controlled Study Followed by an Open-Label Extension Period to Evaluate the Activity of Seladelpar in Subjects with Nonalcoholic Steatohepatitis (NASH) OLE phase was not analyzed due to the early termination of the study
Study identification
- NCT ID
- NCT03551522
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 181 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 29, 2018
- Primary completion
- May 7, 2019
- Completion
- Aug 9, 2020
- Last update posted
- Sep 14, 2022
2018 – 2020
United States locations
- U.S. sites
- 14
- U.S. states
- 6
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CymaBay Research Site | Glendale | Arizona | 85306 | — |
| CymaBay Research Site | Tucson | Arizona | 85712 | — |
| CymaBay Research Site | Los Angeles | California | 90057 | — |
| CymaBay Research Site | Boca Raton | Florida | 33434 | — |
| CymaBay Research Site | Lakewood Rch | Florida | 34211 | — |
| CymaBay Research Site | Flowood | Mississippi | 39232 | — |
| CymaBay Research Site | Clarksville | Tennessee | 37040 | — |
| CymaBay Research Site | Germantown | Tennessee | 38138 | — |
| CymaBay Research Site | Hermitage | Tennessee | 37076 | — |
| CymaBay Research Site | Knoxville | Tennessee | 37909 | — |
| CymaBay Research Site | Chandler | Texas | 85224 | — |
| CymaBay Research Site | Dallas | Texas | 75246 | — |
| CymaBay Research Site | Live Oak | Texas | 78233 | — |
| CymaBay Research Site | Rollingwood | Texas | 78746 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03551522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2022 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03551522 live on ClinicalTrials.gov.